Literature DB >> 34716260

MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.

Alyssa M Klein1,2, Lynn Biderman1, David Tong1, Bita Alaghebandan1, Sakina A Plumber1, Helen S Mueller1, Anne van Vlimmeren1, Chen Katz3, Carol Prives3.   

Abstract

The p53 tumor suppressor protein, known to be critically important in several processes including cell-cycle arrest and apoptosis, is highly regulated by multiple mechanisms, most certifiably the Murine Double Minute 2-Murine Double Minute X (MDM2-MDMX) heterodimer. The role of MDM2-MDMX in cell-cycle regulation through inhibition of p53 has been well established. Here we report that in cells either lacking p53 or expressing certain tumor-derived mutant forms of p53, loss of endogenous MDM2 or MDMX, or inhibition of E3 ligase activity of the heterocomplex, causes cell-cycle arrest. This arrest is correlated with a reduction in E2F1, E2F3, and p73 levels. Remarkably, direct ablation of endogenous p73 produces a similar effect on the cell cycle and the expression of certain E2F family members at both protein and messenger RNA levels. These data suggest that MDM2 and MDMX, working at least in part as a heterocomplex, may play a p53-independent role in maintaining cell-cycle progression by promoting the activity of E2F family members as well as p73, making them a potential target of interest in cancers lacking wild-type p53.

Entities:  

Keywords:  E2F1; MDM2; MDMX; cell cycle; p73

Mesh:

Substances:

Year:  2021        PMID: 34716260      PMCID: PMC8612355          DOI: 10.1073/pnas.2102420118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  90 in total

1.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein.

Authors:  Gordon D Strachan; Kelly L Jordan-Sciutto; Ravikumar Rallapalli; Rocky S Tuan; David J Hall
Journal:  J Cell Biochem       Date:  2003-02-15       Impact factor: 4.429

Review 3.  The E2F family: specific functions and overlapping interests.

Authors:  Claire Attwooll; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

4.  Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.

Authors:  Ian R Watson; Alvaro Blanch; Dan C C Lin; Michael Ohh; Meredith S Irwin
Journal:  J Biol Chem       Date:  2006-09-14       Impact factor: 5.157

5.  p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.

Authors:  Sung-Hwan Moon; Chun-Hao Huang; Shauna L Houlihan; Kausik Regunath; William A Freed-Pastor; John P Morris; Darjus F Tschaharganeh; Edward R Kastenhuber; Anthony M Barsotti; Rachel Culp-Hill; Wen Xue; Yu-Jui Ho; Timour Baslan; Xiang Li; Allison Mayle; Elisa de Stanchina; Lars Zender; David R Tong; Angelo D'Alessandro; Scott W Lowe; Carol Prives
Journal:  Cell       Date:  2018-12-20       Impact factor: 41.582

6.  The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Kalkunte S Srivenugopal; Subhasree Nag; Shivaputra Patil; Horrick Sharma; Ming-Hai Wang; Hui Wang; John K Buolamwini; Ruiwen Zhang
Journal:  Nat Commun       Date:  2014-10-01       Impact factor: 14.919

7.  MDM2 and MDMX bind and stabilize the p53-related protein p73.

Authors:  W M Ongkeko; X Q Wang; W Y Siu; A W Lau; K Yamashita; A L Harris; L S Cox; R Y Poon
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

8.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

Review 9.  MDM2 oligomers: antagonizers of the guardian of the genome.

Authors:  P L Leslie; Y Zhang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

Review 10.  The roles and regulation of MDM2 and MDMX: it is not just about p53.

Authors:  Alyssa M Klein; Rafaela Muniz de Queiroz; Divya Venkatesh; Carol Prives
Journal:  Genes Dev       Date:  2021-04-22       Impact factor: 11.361

View more
  2 in total

Review 1.  Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials.

Authors:  Haohao Zhu; Hui Gao; Yingying Ji; Qin Zhou; Zhiqiang Du; Lin Tian; Ying Jiang; Kun Yao; Zhenhe Zhou
Journal:  J Hematol Oncol       Date:  2022-07-13       Impact factor: 23.168

2.  Functional interaction between S100A1 and MDM2 may modulate p53 signaling in normal and malignant endometrial cells.

Authors:  Mayu Nakagawa; Shyoma Higuchi; Miki Hashimura; Yasuko Oguri; Toshihide Matsumoto; Ako Yokoi; Yu Ishibashi; Takashi Ito; Makoto Saegusa
Journal:  BMC Cancer       Date:  2022-02-18       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.